What are the key features of Crohn's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Key Features of Crohn's Disease

Crohn's disease is a chronic inflammatory disorder characterized by transmural inflammation that can affect any part of the gastrointestinal tract, typically presenting with skip lesions, stricturing or penetrating complications, and perianal involvement. 1

Anatomical Distribution and Location

  • Can involve any portion of the GI tract from mouth to anus, distinguishing it fundamentally from ulcerative colitis which is limited to the colon 2, 3
  • Terminal ileum is the most commonly affected site, with approximately one-third of patients having small bowel involvement alone, slightly more having colonic disease alone, and less than one-third having combined small bowel and colonic disease 1, 2
  • Demonstrates patchy, discontinuous, segmental inflammation with skip lesions—meaning normal bowel segments separate inflamed areas 2, 3
  • Rectal sparing is common, which strongly favors Crohn's over ulcerative colitis 1, 3

Pathologic Characteristics

Transmural Inflammation

  • Extends through all layers of the intestinal wall (mucosa, submucosa, muscularis propria, and serosa), not just the mucosa as in ulcerative colitis 2, 3
  • This full-thickness involvement is the defining pathologic feature that drives development of stricturing and penetrating complications 2
  • Granulomatous inflammation is characteristic, though non-caseating granulomas are present in only a minority of biopsy samples 1

Pattern of Inflammation

  • Asymmetric involvement is typical, particularly along the mesenteric border, rather than circumferential 2, 3
  • Focal crypt architectural irregularity and chronic inflammation that varies in intensity within and between biopsies 1, 2
  • Chronic histological changes include architectural distortion, crypt atrophy, increased lamina propria chronic inflammatory cells, and Paneth cell metaplasia 1

Disease Complications and Phenotypes

Three Main Disease Phenotypes

  • Inflammatory phenotype: Active mucosal and transmural inflammation without stricturing or penetrating behavior 1
  • Stricturing phenotype: Progressive structural damage leads to luminal narrowing with upstream bowel dilation 1
  • Penetrating phenotype: Fistulas, sinuses, abscesses, or inflammatory masses 1

Penetrating Complications

  • Fistulas represent a hallmark complication, arising from transmural inflammation that creates abnormal connections between bowel loops or to adjacent structures 2, 3
  • Approximately one-quarter of perianal fistulas present at or before diagnosis 2, 3
  • Fistulas typically arise from within or just proximal to strictures and can be simple or complex 2

Stricture Formation

  • Defined as luminal narrowing with unequivocal upstream dilation (upstream lumen >3 cm) 1
  • Most Crohn's strictures contain both inflammation and fibrosis 1
  • Progressive structural damage occurs over time with recurrent inflammation, even when bowel returns to normal appearance after acute flares 1

Perianal Disease

  • Occurs in up to one-third of patients as a distinct manifestation 1
  • Can include perianal fistulas, abscesses, and fissures 1

Imaging and Endoscopic Features

Cross-Sectional Imaging Findings

  • Asymmetric wall thickening, hyperenhancement, and mural edema (T2-weighted signal on MRI) are specific for active Crohn's disease 1
  • Ulcerations appear as focal breaks in the bowel wall surface and correlate with severe endoscopic inflammation 1
  • Mural stratification (layered enhancement pattern) can be seen with active inflammation 1
  • Perienteric fat stranding and mesenteric lymphadenopathy indicate more severe disease 1

Endoscopic Characteristics

  • Skip lesions with intervening normal mucosa 1, 3
  • Deep, linear, or serpiginous ulcerations that can lead to a "cobblestone" appearance 1
  • Discontinuous distribution between anatomical sites 1

Clinical Course

  • Characterized by episodic flares and periods of remission with increasing incidence over recent decades 1
  • Active inflammation can exist despite clinical resolution of symptoms, making endoscopy and imaging central tools for disease monitoring 1
  • Mucosal healing represents a better treatment target for long-term outcomes than reliance on clinical symptoms alone 1
  • Most patients will eventually require surgery, though surgery is not curative and ongoing therapy is needed for disease recurrence 4

Diagnostic Approach

  • No single diagnostic test allows unequivocal diagnosis—requires combination of clinical, laboratory, endoscopic, histological, and imaging findings 1
  • Complete ileocolonoscopy with biopsies from at least five different sites (at least two from terminal ileum, four colonic segments, and rectum) is essential 1, 5
  • Cross-sectional imaging (CT or MR enterography) is complementary to endoscopy, allowing evaluation of disease proximal to the ileum and detection of transmural disease with normal-appearing mucosa 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Characteristic Features of Crohn's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Key Differences Between Crohn's Disease and Ulcerative Colitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ulcerative Colitis and Crohn's Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best treatment for a 20-year-old woman with suspected Crohn's disease, characterized by structuring of the terminal ileum and dilation of the proximal small intestine?
What is the most appropriate next step in a 28-year-old patient with perianal discharge, intermittent abdominal pain, family history of Crohn disease, and three perianal fistula openings at 3, 7, and 9 o’clock?
In a 7‑year‑old child with chronic diarrhea and colonoscopy showing skip lesions with terminal ileum inflammation consistent with Crohn disease, should the initial induction therapy be exclusive enteral nutrition, systemic corticosteroids, or methotrexate?
What is the first-line therapy to induce remission in a 13-year-old girl with Crohn disease presenting with chronic diarrhea and transmural inflammation on colonoscopy?
In a 13-year-old female with chronic diarrhea for 3–4 months and colonoscopy showing transmural inflammation consistent with Crohn disease, what is the preferred first‑line therapy for induction of remission?
What is the recommended approach to reverse rivaroxaban anticoagulation for urgent hemostasis in a patient with life‑threatening bleeding or requiring emergency surgery?
Which tumor marker is most commonly used for rectal cancer and how should it be measured and employed for monitoring treatment response and detecting recurrence?
In a patient with metastatic malignant phyllodes tumor of the breast with bilateral pleural and right interlobar and subcarinal nodal metastases, after three cycles of gemcitabine (1000 mg/m² days 1 and 8) plus docetaxel (75 mg/m² day 1) every 21 days, PET‑CT shows decreased standardized uptake value but increased lesion size with central necrosis, no new disease, and a right‑sided multiloculated pleural effusion, ECOG (Eastern Cooperative Oncology Group) performance status 1, what is the recommended next treatment approach?
Can vitamin K, fresh frozen plasma, or cryoprecipitate be used to reverse rivaroxaban in a patient with life‑threatening bleeding or requiring emergency surgery?
What is the term for a shortened perineum?
What are the diagnostic criteria and initial management steps for gestational hypertension in a pregnant woman after 20 weeks gestation without prior chronic hypertension or proteinuria?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.